CAVEI updated its recommendations on the second booster dose of the COVID-19 vaccine: 1) CAVEI supports the MoH strategy of offering a second booster dose to people with immunosuppression, health workers and residents and workers of ELEAM with COVID-19 vaccine preferably based on messenger RNA an

Administered five to six months after the second booster, in persons over 65, immunosuppressed persons over 65, immunosuppressed persons, chronically ill persons and health care workers with chronic diseases. Preferably, administer the SARS-CoV-2 messenger RNA-based platform vaccine.

Participation of Chile in PAHO-WHO international activities: 1) Summary Meeting Geneva March 13 - 15, 2023; 2) Meeting Summary Rio de Janeiro March 13 - 15, 2023. Diagnosis and proposal of minimum contents on vaccines and immunizations in training entities of health careers.